Award
National Institute of Allergy and Infectious Diseases 4UM1AI164556-06
I4C 2.0: Immunotherapy for Cure
Recipient
Not Specified
Award Amount
$4,653,643.00
Ceiling
$4,653,643.00
Awarded
August 01, 2026
Identifier
4UM1AI164556-06
Award for advancing immunologic strategies for HIV-1 remission and eradication managed by NIAID with a project duration from 2021 to 2028.
Description
The project focuses on advancing immunologic strategies for HIV-1 remission and eradication. The award is managed by the National Institute of Allergy and Infectious Diseases. The project involves multiple research aims including reservoir targeting, immune engineering, and virus eradication. The project duration is from August 16, 2021, to June 30, 2028. The funding supports partnerships among academia, industry, government, and the community.